Last reviewed · How we verify
NCT03091816
Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer
trial testing Computed Tomography Perfusion Imaging in Stage IA Non-Small Cell Lung Carcinoma in 15 participants. Completed in 7 March 2024.
2 March 2023
Quick facts
| Lead sponsor | University of Southern California |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 15 |
| Start date | 8 May 2017 |
| Primary completion | 2 March 2023 |
| Estimated completion | 7 March 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Computed Tomography Perfusion Imaging
- Laboratory Biomarker Analysis — full drug profile →
- Stereotactic Body Radiation Therapy — full drug profile →
Conditions studied
- Stage IA Non-Small Cell Lung Carcinoma — all drugs for Stage IA Non-Small Cell Lung Carcinoma →
- Stage IB Non-Small Cell Lung Carcinoma — all drugs for Stage IB Non-Small Cell Lung Carcinoma →
- Stage IIA Non-Small Cell Lung Carcinoma — all drugs for Stage IIA Non-Small Cell Lung Carcinoma →
- Stage IIB Non-Small Cell Lung Carcinoma — all drugs for Stage IIB Non-Small Cell Lung Carcinoma →
Sponsor
University of Southern California
Who can join
18 and older, any sex, with Stage IA Non-Small Cell Lung Carcinoma or Stage IB Non-Small Cell Lung Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pilot clinical trial studies the changes in dynamic perfusion computed tomography images before, during, and after stereotactic body radiation therapy in patients with stage I-II non-small cell lung cancer that has not spread to other parts of the body. Diagnostic imaging procedures, such as dynamic perfusion computed tomography, measure blood flow through tumors. Stereotactic body radiation therapy is a specialized radiation therapy that sends x-rays directly to the tumor using smaller doses over several days and may cause less damage to normal tissue. Giving dynamic perfusion computed tomography images before, during, and after stereotactic body radiation therapy may help better understand how radiation therapy works to stop tumor growth in patients with non-small cell lung cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03091816
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Computed Tomography Perfusion Imaging
Trials testing the same drug.
- NCT03412630 — Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab · NA · terminated
- NCT03990623 — CT Perfusion Scans in Detecting Changes in Blood Flow to the Liver After Portal Vein Embolization · NA · unknown
- NCT03012282 — CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer · NA · terminated
- NCT02960308 — Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors · completed
- NCT02693080 — CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Tre · Phase 1 · completed
Other University of Southern California trials
Trials by the same sponsor.
- NCT07288463 — Hearing Loss and Genetic Risks for Alzheimer's Disease and Related Dementia · NA · not yet recruiting
- NCT05914233 — Non-invasive Ultrasound Retinal Stimulation for Vision Restoration · NA · not yet recruiting
- NCT06163664 — Role of ChatGPT in Vestibular Schwannoma Management · NA · withdrawn
- NCT07332312 — A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Ind · NA · not yet recruiting
- NCT07290478 — Encouraging Older Adults and Adults With Serious Illness to Designate a Health Care Proxy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03091816 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Southern California
- Last refreshed: 11 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03091816.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing